Published on
October 5, 2016
- 14:54 GMT
CoLucid Pharmaceuticals Announces Additional Analyses of Lasmiditan’s Onset of Action Data from SAMURAI and Supporting Non-...
Lasmiditan (100 mg and 200 mg) oral tablets had onset of action and provided significant headache pain relief as soon as 30 minutes after dosing (p ≤ 0.004) and freedom from the most bothersome symptom (MBS) as soon as 30 minutes after dosing (p ≤ 0.015) …
Distribution channels:
Healthcare & Pharmaceuticals Industry
